We treated HCC1806 and SUM149PT cells with CDK4/6 inhibitors (Palbociclib, Ribociclib and Abemaciclib) and KPT‐330, they all showed good anti‐tumor activity, Abemaciclib was more effective than the other two drugs (Figure S5A, Supporting Information). Here, CDK4 is linked to neoplasm.